These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15378094)

  • 41. The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer.
    Headley JA; Ownby KK; John LD
    Oncol Nurs Forum; 2004 Sep; 31(5):977-83. PubMed ID: 15378098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
    Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
    Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical subgroups of a psychoneurologic symptom cluster in women receiving treatment for breast cancer: a secondary analysis.
    Kim HJ; Barsevick AM; Beck SL; Dudley W
    Oncol Nurs Forum; 2012 Jan; 39(1):E20-30. PubMed ID: 22201665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation.
    Grulke N; Larbig W; Kächele H; Bailer H
    Psychooncology; 2008 May; 17(5):480-7. PubMed ID: 17879971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.
    Russell N; Mesters R; Schubert J; Boogaerts M; Johnsen HE; Canizo CD; Baker N; Barker P; Skacel T; Schmitz N
    Haematologica; 2008 Mar; 93(3):405-12. PubMed ID: 18268285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
    Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship of fatigue and meaning in life in breast cancer survivors.
    Thompson P
    Oncol Nurs Forum; 2007 May; 34(3):653-60. PubMed ID: 17573324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experiences of fatigue and self-management of Thai Buddhist cancer patients undergoing radiation therapy.
    Lundberg PC; Rattanasuwan O
    Cancer Nurs; 2007; 30(2):146-55. PubMed ID: 17413780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1,482 patients transplanted in 1990-2003.
    Jantunen E; Itälä M; Siitonen T; Koivunen E; Leppä S; Juvonen E; Kuittinen O; Lehtinen T; Koistinen P; Nyman H; Nousiainen T; Volin L; Remes K
    Eur J Haematol; 2006 Aug; 77(2):114-9. PubMed ID: 16856906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
    Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD
    Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F; Cavenaghi L; de Melo CM
    Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Necessary harmonization of health cost assessment. Autologous peripheral blood progenitor cell transplantation in France].
    Perrier L; Sebban C; Philip I; Standaert B; Morelle M; Latour JF; Biron P; Philip T
    Rev Epidemiol Sante Publique; 2002 Sep; 50(4):393-403. PubMed ID: 12442056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physical activity and fatigue during radiation therapy: a pilot study using actigraph monitors.
    Sarna L; Conde F
    Oncol Nurs Forum; 2001 Jul; 28(6):1043-6. PubMed ID: 11475878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fatigue in patients with cancer receiving interferon alpha.
    Dean GE; Spears L; Ferrell BR; Quan WD; Groshon S; Mitchell MS
    Cancer Pract; 1995; 3(3):164-72. PubMed ID: 7599673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of health state, hemoglobin, global symptom distress, mood disturbance, and treatment site on fatigue onset, duration, and distress in patients receiving radiation therapy.
    Magnan MA; Mood DW
    Oncol Nurs Forum; 2003; 30(2):E33-9. PubMed ID: 12692668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients.
    Ruiz-Soto R; Sergent G; Gisselbrecht C; Larghero J; Ertault M; Hennequin C; Manson J; de Kerviler E; Briere J; Mounier N
    Cancer; 2005 Dec; 104(12):2735-42. PubMed ID: 16284986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
    Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D
    Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetics of peg-filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
    Piccirillo N; De Matteis S; De Vita S; Laurenti L; Chiusolo P; Sorà F; Reddiconto G; d'Onofrio G; Leone G; Sica S
    Bone Marrow Transplant; 2007 Sep; 40(6):579-83. PubMed ID: 17637690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.